nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—CDA—hematologic cancer	0.182	1	CbGaD
Capecitabine—Nucleic Acid Synthesis Inhibitors—Pentostatin—hematologic cancer	0.118	0.235	CiPCiCtD
Capecitabine—Nucleic Acid Synthesis Inhibitors—Nelarabine—hematologic cancer	0.118	0.235	CiPCiCtD
Capecitabine—Nucleic Acid Synthesis Inhibitors—Clofarabine—hematologic cancer	0.118	0.235	CiPCiCtD
Capecitabine—Nucleic Acid Synthesis Inhibitors—Cytarabine—hematologic cancer	0.0895	0.178	CiPCiCtD
Capecitabine—CDA—Cytarabine—hematologic cancer	0.0703	0.392	CbGbCtD
Capecitabine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—hematologic cancer	0.0576	0.115	CiPCiCtD
Capecitabine—CDA—Gemcitabine—hematologic cancer	0.0428	0.238	CbGbCtD
Capecitabine—TYMS—Gemcitabine—hematologic cancer	0.0191	0.106	CbGbCtD
Capecitabine—CES1—Irinotecan—hematologic cancer	0.0133	0.0738	CbGbCtD
Capecitabine—TYMS—Methotrexate—hematologic cancer	0.00899	0.0501	CbGbCtD
Capecitabine—CYP2C9—Bexarotene—hematologic cancer	0.00479	0.0267	CbGbCtD
Capecitabine—CYP2C9—Idarubicin—hematologic cancer	0.00397	0.0221	CbGbCtD
Capecitabine—CYP2C9—Bortezomib—hematologic cancer	0.00294	0.0164	CbGbCtD
Capecitabine—CYP2C9—Thalidomide—hematologic cancer	0.00256	0.0143	CbGbCtD
Capecitabine—CYP2C9—Teniposide—hematologic cancer	0.00244	0.0136	CbGbCtD
Capecitabine—CYP2C9—Ifosfamide—hematologic cancer	0.00225	0.0126	CbGbCtD
Capecitabine—CYP2C9—Imatinib—hematologic cancer	0.00215	0.012	CbGbCtD
Capecitabine—CYP2C9—Nilotinib—hematologic cancer	0.00196	0.0109	CbGbCtD
Capecitabine—CDA—hematopoietic system—hematologic cancer	0.00124	0.0775	CbGeAlD
Capecitabine—CYP2C9—Cisplatin—hematologic cancer	0.0011	0.00611	CbGbCtD
Capecitabine—CYP2C9—Dexamethasone—hematologic cancer	0.000885	0.00493	CbGbCtD
Capecitabine—DPYD—blood—hematologic cancer	0.000853	0.0534	CbGeAlD
Capecitabine—DPYD—bone marrow—hematologic cancer	0.000825	0.0517	CbGeAlD
Capecitabine—CDA—blood—hematologic cancer	0.000821	0.0514	CbGeAlD
Capecitabine—CDA—bone marrow—hematologic cancer	0.000794	0.0497	CbGeAlD
Capecitabine—DPYD—lung—hematologic cancer	0.000748	0.0468	CbGeAlD
Capecitabine—TYMP—hematopoietic system—hematologic cancer	0.000746	0.0467	CbGeAlD
Capecitabine—DPYD—testis—hematologic cancer	0.000706	0.0442	CbGeAlD
Capecitabine—CDA—testis—hematologic cancer	0.000679	0.0425	CbGeAlD
Capecitabine—CES1—hematopoietic system—hematologic cancer	0.000644	0.0403	CbGeAlD
Capecitabine—TYMS—hematopoietic system—hematologic cancer	0.00064	0.0401	CbGeAlD
Capecitabine—DPYD—lymph node—hematologic cancer	0.000511	0.032	CbGeAlD
Capecitabine—TYMP—blood—hematologic cancer	0.000494	0.0309	CbGeAlD
Capecitabine—CDA—lymph node—hematologic cancer	0.000492	0.0308	CbGeAlD
Capecitabine—TYMS—gonad—hematologic cancer	0.000487	0.0305	CbGeAlD
Capecitabine—TYMP—bone marrow—hematologic cancer	0.000478	0.0299	CbGeAlD
Capecitabine—TYMP—lung—hematologic cancer	0.000433	0.0271	CbGeAlD
Capecitabine—CES1—blood—hematologic cancer	0.000427	0.0267	CbGeAlD
Capecitabine—TYMS—blood—hematologic cancer	0.000424	0.0265	CbGeAlD
Capecitabine—TYMS—bone marrow—hematologic cancer	0.00041	0.0257	CbGeAlD
Capecitabine—TYMP—testis—hematologic cancer	0.000409	0.0256	CbGeAlD
Capecitabine—CES1—lung—hematologic cancer	0.000374	0.0234	CbGeAlD
Capecitabine—TYMS—lung—hematologic cancer	0.000372	0.0233	CbGeAlD
Capecitabine—CES1—testis—hematologic cancer	0.000353	0.0221	CbGeAlD
Capecitabine—TYMS—testis—hematologic cancer	0.000351	0.022	CbGeAlD
Capecitabine—TYMP—lymph node—hematologic cancer	0.000296	0.0185	CbGeAlD
Capecitabine—CYP2C9—hematopoietic system—hematologic cancer	0.000279	0.0175	CbGeAlD
Capecitabine—CES1—lymph node—hematologic cancer	0.000256	0.016	CbGeAlD
Capecitabine—TYMS—lymph node—hematologic cancer	0.000254	0.0159	CbGeAlD
Capecitabine—CYP2C9—blood—hematologic cancer	0.000185	0.0116	CbGeAlD
Capecitabine—TYMS—Nilotinib—Imatinib—hematologic cancer	0.000162	0.139	CbGdCrCtD
Capecitabine—TYMS—Vitamin A—Alitretinoin—hematologic cancer	9.75e-05	0.0837	CbGdCrCtD
Capecitabine—TYMS—Tretinoin—Alitretinoin—hematologic cancer	6.82e-05	0.0585	CbGdCrCtD
Capecitabine—TYMS—Isotretinoin—Alitretinoin—hematologic cancer	6.82e-05	0.0585	CbGdCrCtD
Capecitabine—TYMS—Podofilox—Teniposide—hematologic cancer	6.79e-05	0.0583	CbGdCrCtD
Capecitabine—TYMS—Menadione—Thalidomide—hematologic cancer	5.15e-05	0.0442	CbGdCrCtD
Capecitabine—TYMS—Vincristine—Vinorelbine—hematologic cancer	4.32e-05	0.0371	CbGdCrCtD
Capecitabine—TYMS—Vinorelbine—Vinblastine—hematologic cancer	4.04e-05	0.0347	CbGdCrCtD
Capecitabine—TYMS—Vinorelbine—Vincristine—hematologic cancer	4.04e-05	0.0347	CbGdCrCtD
Capecitabine—TYMS—Podofilox—Etoposide—hematologic cancer	4.04e-05	0.0347	CbGdCrCtD
Capecitabine—TYMS—Vinblastine—Vinorelbine—hematologic cancer	3.48e-05	0.0299	CbGdCrCtD
Capecitabine—TYMS—Vincristine—Vinblastine—hematologic cancer	3.46e-05	0.0297	CbGdCrCtD
Capecitabine—TYMS—Vinblastine—Vincristine—hematologic cancer	2.78e-05	0.0239	CbGdCrCtD
Capecitabine—TYMS—Azacitidine—Pentostatin—hematologic cancer	2.64e-05	0.0226	CbGdCrCtD
Capecitabine—TYMS—Azacitidine—Clofarabine—hematologic cancer	2.35e-05	0.0202	CbGdCrCtD
Capecitabine—TYMS—Azacitidine—Nelarabine—hematologic cancer	2.21e-05	0.019	CbGdCrCtD
Capecitabine—TYMS—Azacitidine—Fludarabine—hematologic cancer	1.72e-05	0.0148	CbGdCrCtD
Capecitabine—TYMS—Azacitidine—Gemcitabine—hematologic cancer	1.63e-05	0.014	CbGdCrCtD
Capecitabine—TYMS—Azacitidine—Cytarabine—hematologic cancer	1.63e-05	0.014	CbGdCrCtD
Capecitabine—TYMS—Azacitidine—Cladribine—hematologic cancer	1.59e-05	0.0136	CbGdCrCtD
Capecitabine—CDA—Metabolism—NQO1—hematologic cancer	1.05e-05	0.000313	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CD44—hematologic cancer	1.05e-05	0.000313	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDK6—hematologic cancer	1.04e-05	0.000313	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—UGT1A1—hematologic cancer	1.04e-05	0.000311	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ENO2—hematologic cancer	1.04e-05	0.000311	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	1.03e-05	0.00031	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.03e-05	0.000309	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GBA—hematologic cancer	1.03e-05	0.000309	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SLC35B2—hematologic cancer	1.03e-05	0.000309	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GSTT1—hematologic cancer	1.01e-05	0.000301	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCND2—hematologic cancer	1e-05	0.000301	CbGpPWpGaD
Capecitabine—TYMS—Clobetasol propionate—Betamethasone—hematologic cancer	1e-05	0.00861	CbGdCrCtD
Capecitabine—TYMS—Clobetasol propionate—Dexamethasone—hematologic cancer	1e-05	0.00861	CbGdCrCtD
Capecitabine—TYMS—Flunisolide—Betamethasone—hematologic cancer	9.9e-06	0.0085	CbGdCrCtD
Capecitabine—TYMS—Flunisolide—Dexamethasone—hematologic cancer	9.9e-06	0.0085	CbGdCrCtD
Capecitabine—CDA—Metabolism—CYCS—hematologic cancer	9.9e-06	0.000297	CbGpPWpGaD
Capecitabine—CDA—Metabolism—HSP90AA1—hematologic cancer	9.84e-06	0.000295	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—SDC1—hematologic cancer	9.84e-06	0.000295	CbGpPWpGaD
Capecitabine—TYMS—Clobetasol propionate—Triamcinolone—hematologic cancer	9.8e-06	0.00842	CbGdCrCtD
Capecitabine—TYMS—Triamcinolone—Dexamethasone—hematologic cancer	9.8e-06	0.00841	CbGdCrCtD
Capecitabine—TYMS—Triamcinolone—Betamethasone—hematologic cancer	9.8e-06	0.00841	CbGdCrCtD
Capecitabine—DPYD—Metabolism—GSTP1—hematologic cancer	9.79e-06	0.000293	CbGpPWpGaD
Capecitabine—TYMS—Flunisolide—Triamcinolone—hematologic cancer	9.67e-06	0.00831	CbGdCrCtD
Capecitabine—TYMS—Fluticasone Propionate—Dexamethasone—hematologic cancer	9.56e-06	0.00821	CbGdCrCtD
Capecitabine—TYMS—Fluticasone Propionate—Betamethasone—hematologic cancer	9.56e-06	0.00821	CbGdCrCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—MYC—hematologic cancer	9.51e-06	0.000285	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	9.47e-06	0.000284	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—MTAP—hematologic cancer	9.42e-06	0.000282	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	9.42e-06	0.000282	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—HSP90AA1—hematologic cancer	9.36e-06	0.00028	CbGpPWpGaD
Capecitabine—TYMS—Fluticasone Propionate—Triamcinolone—hematologic cancer	9.34e-06	0.00802	CbGdCrCtD
Capecitabine—TYMS—Clobetasol propionate—Prednisone—hematologic cancer	9.3e-06	0.00799	CbGdCrCtD
Capecitabine—DPYD—Metabolism—ABCB1—hematologic cancer	9.27e-06	0.000278	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	9.23e-06	0.000276	CbGpPWpGaD
Capecitabine—TYMS—Flunisolide—Prednisone—hematologic cancer	9.18e-06	0.00788	CbGdCrCtD
Capecitabine—CYP2C9—Biological oxidations—MTR—hematologic cancer	9.12e-06	0.000273	CbGpPWpGaD
Capecitabine—TYMS—Triamcinolone—Prednisone—hematologic cancer	9.09e-06	0.0078	CbGdCrCtD
Capecitabine—TYMS—Clobetasol propionate—Prednisolone—hematologic cancer	9.08e-06	0.0078	CbGdCrCtD
Capecitabine—TYMS—Diflorasone—Dexamethasone—hematologic cancer	9.03e-06	0.00776	CbGdCrCtD
Capecitabine—TYMS—Diflorasone—Betamethasone—hematologic cancer	9.03e-06	0.00776	CbGdCrCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN2B—hematologic cancer	9e-06	0.00027	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—NCOR1—hematologic cancer	9e-06	0.000269	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GSTM1—hematologic cancer	9e-06	0.000269	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	8.98e-06	0.000269	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CCND2—hematologic cancer	8.98e-06	0.000269	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	8.96e-06	0.000268	CbGpPWpGaD
Capecitabine—TYMS—Flunisolide—Prednisolone—hematologic cancer	8.96e-06	0.00769	CbGdCrCtD
Capecitabine—TYMS—Triamcinolone—Prednisolone—hematologic cancer	8.87e-06	0.00762	CbGdCrCtD
Capecitabine—TYMS—Diflorasone—Triamcinolone—hematologic cancer	8.82e-06	0.00758	CbGdCrCtD
Capecitabine—CDA—Metabolism—GSTP1—hematologic cancer	8.73e-06	0.000261	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	8.69e-06	0.00026	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GSTT1—hematologic cancer	8.68e-06	0.00026	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	8.67e-06	0.00026	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—JUN—hematologic cancer	8.6e-06	0.000258	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	8.48e-06	0.000254	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—FHL2—hematologic cancer	8.4e-06	0.000252	CbGpPWpGaD
Capecitabine—TYMS—Diflorasone—Prednisone—hematologic cancer	8.37e-06	0.00719	CbGdCrCtD
Capecitabine—TYMP—Metabolism—NQO1—hematologic cancer	8.36e-06	0.000251	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CD44—hematologic cancer	8.36e-06	0.000251	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—PTEN—hematologic cancer	8.32e-06	0.000249	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	8.27e-06	0.000248	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ABCB1—hematologic cancer	8.26e-06	0.000247	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AGRN—hematologic cancer	8.24e-06	0.000247	CbGpPWpGaD
Capecitabine—TYMS—Diflorasone—Prednisolone—hematologic cancer	8.17e-06	0.00702	CbGdCrCtD
Capecitabine—TYMS—Circadian rythm related genes—MAPK8—hematologic cancer	8.14e-06	0.000244	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN2B—hematologic cancer	8.05e-06	0.000241	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	8.04e-06	0.000241	CbGpPWpGaD
Capecitabine—CDA—Metabolism—NCOR1—hematologic cancer	8.02e-06	0.00024	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GSTM1—hematologic cancer	8.02e-06	0.00024	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—MTHFR—hematologic cancer	7.95e-06	0.000238	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—EP300—hematologic cancer	7.94e-06	0.000238	CbGpPWpGaD
Capecitabine—TYMS—Budesonide—Dexamethasone—hematologic cancer	7.92e-06	0.0068	CbGdCrCtD
Capecitabine—TYMS—Budesonide—Betamethasone—hematologic cancer	7.92e-06	0.0068	CbGdCrCtD
Capecitabine—TYMP—Metabolism—CYCS—hematologic cancer	7.91e-06	0.000237	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—HSP90AA1—hematologic cancer	7.86e-06	0.000236	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	7.83e-06	0.000235	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—IDH2—hematologic cancer	7.81e-06	0.000234	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HMMR—hematologic cancer	7.81e-06	0.000234	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—BIRC5—hematologic cancer	7.77e-06	0.000233	CbGpPWpGaD
Capecitabine—TYMS—Budesonide—Triamcinolone—hematologic cancer	7.74e-06	0.00664	CbGdCrCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	7.41e-06	0.000222	CbGpPWpGaD
Capecitabine—TYMS—Budesonide—Prednisone—hematologic cancer	7.34e-06	0.0063	CbGdCrCtD
Capecitabine—TYMS—Metabolism—ARNTL—hematologic cancer	7.34e-06	0.00022	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	7.2e-06	0.000216	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	7.19e-06	0.000215	CbGpPWpGaD
Capecitabine—TYMS—Budesonide—Prednisolone—hematologic cancer	7.17e-06	0.00615	CbGdCrCtD
Capecitabine—TYMS—Metabolism—CA9—hematologic cancer	7.14e-06	0.000214	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ACP5—hematologic cancer	7.14e-06	0.000214	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDK2—hematologic cancer	7.12e-06	0.000213	CbGpPWpGaD
Capecitabine—CDA—Metabolism—MTHFR—hematologic cancer	7.09e-06	0.000212	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NCOR2—hematologic cancer	7.05e-06	0.000211	CbGpPWpGaD
Capecitabine—TYMS—Danazol—Prednisone—hematologic cancer	7.04e-06	0.00604	CbGdCrCtD
Capecitabine—TYMP—Metabolism—GSTP1—hematologic cancer	6.98e-06	0.000209	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—BIRC5—hematologic cancer	6.94e-06	0.000208	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDK4—hematologic cancer	6.73e-06	0.000202	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TERT—hematologic cancer	6.73e-06	0.000201	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—IDH1—hematologic cancer	6.71e-06	0.000201	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	6.71e-06	0.000201	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CG—hematologic cancer	6.68e-06	0.0002	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	6.67e-06	0.0002	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	6.66e-06	0.000199	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—TXN—hematologic cancer	6.64e-06	0.000199	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTO1—hematologic cancer	6.64e-06	0.000199	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ABCC3—hematologic cancer	6.64e-06	0.000199	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ABCB1—hematologic cancer	6.6e-06	0.000198	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SPHK1—hematologic cancer	6.5e-06	0.000195	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GSTM1—hematologic cancer	6.41e-06	0.000192	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—NCOR1—hematologic cancer	6.41e-06	0.000192	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDK2—hematologic cancer	6.37e-06	0.000191	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—UGT1A1—hematologic cancer	6.24e-06	0.000187	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CREBBP—hematologic cancer	6.19e-06	0.000186	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	6.12e-06	0.000183	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SLC22A1—hematologic cancer	6.07e-06	0.000182	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CRABP1—hematologic cancer	6.07e-06	0.000182	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—ATM—hematologic cancer	6.05e-06	0.000181	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDK4—hematologic cancer	6.02e-06	0.00018	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GSTP1—hematologic cancer	6.01e-06	0.00018	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CG—hematologic cancer	5.95e-06	0.000178	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTP1—hematologic cancer	5.93e-06	0.000178	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ALOX5—hematologic cancer	5.92e-06	0.000177	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	5.92e-06	0.000177	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CD—hematologic cancer	5.87e-06	0.000176	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—RB1—hematologic cancer	5.85e-06	0.000175	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ALB—hematologic cancer	5.8e-06	0.000174	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NUP98—hematologic cancer	5.73e-06	0.000172	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—TP53—hematologic cancer	5.68e-06	0.00017	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—MTHFR—hematologic cancer	5.67e-06	0.00017	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ADCY7—hematologic cancer	5.56e-06	0.000167	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NCOA3—hematologic cancer	5.56e-06	0.000167	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3R1—hematologic cancer	5.55e-06	0.000166	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GSTM1—hematologic cancer	5.53e-06	0.000166	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NUP214—hematologic cancer	5.52e-06	0.000165	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CREBBP—hematologic cancer	5.52e-06	0.000165	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTM1—hematologic cancer	5.45e-06	0.000163	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	5.44e-06	0.000163	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—MTR—hematologic cancer	5.41e-06	0.000162	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ABCG2—hematologic cancer	5.41e-06	0.000162	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ENO2—hematologic cancer	5.31e-06	0.000159	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—RB1—hematologic cancer	5.24e-06	0.000157	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CD—hematologic cancer	5.23e-06	0.000157	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—IL6—hematologic cancer	5.2e-06	0.000156	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ALB—hematologic cancer	5.17e-06	0.000155	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTT1—hematologic cancer	5.15e-06	0.000154	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	5.15e-06	0.000154	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CB—hematologic cancer	5.12e-06	0.000153	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SDC1—hematologic cancer	5.03e-06	0.000151	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	5e-06	0.00015	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3R1—hematologic cancer	4.94e-06	0.000148	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CG—hematologic cancer	4.76e-06	0.000143	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	4.75e-06	0.000142	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GMPS—hematologic cancer	4.61e-06	0.000138	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PHYH—hematologic cancer	4.61e-06	0.000138	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—FTCD—hematologic cancer	4.61e-06	0.000138	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN2A—hematologic cancer	4.6e-06	0.000138	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CB—hematologic cancer	4.56e-06	0.000137	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	4.56e-06	0.000137	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	4.56e-06	0.000137	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MDM2—hematologic cancer	4.46e-06	0.000134	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PTEN—hematologic cancer	4.42e-06	0.000132	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CREBBP—hematologic cancer	4.41e-06	0.000132	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCND1—hematologic cancer	4.35e-06	0.00013	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	4.35e-06	0.00013	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	4.3e-06	0.000129	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CD44—hematologic cancer	4.28e-06	0.000128	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NQO1—hematologic cancer	4.28e-06	0.000128	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—EP300—hematologic cancer	4.22e-06	0.000126	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SMPD3—hematologic cancer	4.22e-06	0.000126	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	4.21e-06	0.000126	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	4.21e-06	0.000126	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CD—hematologic cancer	4.18e-06	0.000125	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ALB—hematologic cancer	4.13e-06	0.000124	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN1B—hematologic cancer	4.08e-06	0.000122	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYCS—hematologic cancer	4.05e-06	0.000121	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HSP90AA1—hematologic cancer	4.02e-06	0.00012	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—EP300—hematologic cancer	4e-06	0.00012	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3R1—hematologic cancer	3.95e-06	0.000118	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PTEN—hematologic cancer	3.94e-06	0.000118	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	3.93e-06	0.000118	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CCND1—hematologic cancer	3.89e-06	0.000116	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	3.83e-06	0.000115	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN1A—hematologic cancer	3.76e-06	0.000113	CbGpPWpGaD
Capecitabine—CDA—Metabolism—EP300—hematologic cancer	3.76e-06	0.000113	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ASNS—hematologic cancer	3.68e-06	0.00011	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—DCK—hematologic cancer	3.68e-06	0.00011	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—B3GAT1—hematologic cancer	3.68e-06	0.00011	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CB—hematologic cancer	3.65e-06	0.000109	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	3.6e-06	0.000108	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MAPK3—hematologic cancer	3.59e-06	0.000107	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—EP300—hematologic cancer	3.58e-06	0.000107	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTP1—hematologic cancer	3.57e-06	0.000107	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HDC—hematologic cancer	3.49e-06	0.000105	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MYC—hematologic cancer	3.49e-06	0.000104	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ABCB1—hematologic cancer	3.38e-06	0.000101	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NCOR1—hematologic cancer	3.28e-06	9.82e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTM1—hematologic cancer	3.28e-06	9.82e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	3.26e-06	9.76e-05	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MAPK3—hematologic cancer	3.21e-06	9.6e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CDA—hematologic cancer	3.19e-06	9.57e-05	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PTEN—hematologic cancer	3.15e-06	9.44e-05	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CA—hematologic cancer	3.12e-06	9.35e-05	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MYC—hematologic cancer	3.12e-06	9.34e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PC—hematologic cancer	3.08e-06	9.21e-05	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—EP300—hematologic cancer	3.01e-06	9e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GBA—hematologic cancer	2.97e-06	8.9e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC35B2—hematologic cancer	2.97e-06	8.9e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—MTHFR—hematologic cancer	2.9e-06	8.68e-05	CbGpPWpGaD
Capecitabine—Erythema multiforme—Doxorubicin—hematologic cancer	2.87e-06	3.3e-05	CcSEcCtD
Capecitabine—Rash—Cisplatin—hematologic cancer	2.86e-06	3.29e-05	CcSEcCtD
Capecitabine—Dermatitis—Cisplatin—hematologic cancer	2.86e-06	3.29e-05	CcSEcCtD
Capecitabine—Erythema—Epirubicin—hematologic cancer	2.86e-06	3.29e-05	CcSEcCtD
Capecitabine—Malnutrition—Epirubicin—hematologic cancer	2.86e-06	3.29e-05	CcSEcCtD
Capecitabine—Diarrhoea—Etoposide—hematologic cancer	2.85e-06	3.27e-05	CcSEcCtD
Capecitabine—Anorexia—Prednisone—hematologic cancer	2.84e-06	3.27e-05	CcSEcCtD
Capecitabine—Eye disorder—Doxorubicin—hematologic cancer	2.84e-06	3.26e-05	CcSEcCtD
Capecitabine—Ill-defined disorder—Methotrexate—hematologic cancer	2.83e-06	3.26e-05	CcSEcCtD
Capecitabine—Tinnitus—Doxorubicin—hematologic cancer	2.83e-06	3.26e-05	CcSEcCtD
Capecitabine—Anaemia—Methotrexate—hematologic cancer	2.82e-06	3.25e-05	CcSEcCtD
Capecitabine—Feeling abnormal—Betamethasone—hematologic cancer	2.82e-06	3.24e-05	CcSEcCtD
Capecitabine—Feeling abnormal—Dexamethasone—hematologic cancer	2.82e-06	3.24e-05	CcSEcCtD
Capecitabine—Flushing—Doxorubicin—hematologic cancer	2.82e-06	3.24e-05	CcSEcCtD
Capecitabine—Cardiac disorder—Doxorubicin—hematologic cancer	2.82e-06	3.24e-05	CcSEcCtD
Capecitabine—Flatulence—Epirubicin—hematologic cancer	2.81e-06	3.24e-05	CcSEcCtD
Capecitabine—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.8e-06	3.22e-05	CcSEcCtD
Capecitabine—Gastrointestinal pain—Betamethasone—hematologic cancer	2.8e-06	3.22e-05	CcSEcCtD
Capecitabine—Dysgeusia—Epirubicin—hematologic cancer	2.8e-06	3.22e-05	CcSEcCtD
Capecitabine—CDA—Metabolism—PIK3CA—hematologic cancer	2.78e-06	8.33e-05	CbGpPWpGaD
Capecitabine—Hypersensitivity—Triamcinolone—hematologic cancer	2.78e-06	3.2e-05	CcSEcCtD
Capecitabine—Back pain—Epirubicin—hematologic cancer	2.76e-06	3.18e-05	CcSEcCtD
Capecitabine—Angiopathy—Doxorubicin—hematologic cancer	2.75e-06	3.17e-05	CcSEcCtD
Capecitabine—Malaise—Methotrexate—hematologic cancer	2.75e-06	3.17e-05	CcSEcCtD
Capecitabine—Dizziness—Etoposide—hematologic cancer	2.75e-06	3.16e-05	CcSEcCtD
Capecitabine—Muscle spasms—Epirubicin—hematologic cancer	2.75e-06	3.16e-05	CcSEcCtD
Capecitabine—Immune system disorder—Doxorubicin—hematologic cancer	2.74e-06	3.15e-05	CcSEcCtD
Capecitabine—Vertigo—Methotrexate—hematologic cancer	2.74e-06	3.15e-05	CcSEcCtD
Capecitabine—Mediastinal disorder—Doxorubicin—hematologic cancer	2.74e-06	3.15e-05	CcSEcCtD
Capecitabine—Leukopenia—Methotrexate—hematologic cancer	2.73e-06	3.14e-05	CcSEcCtD
Capecitabine—Chills—Doxorubicin—hematologic cancer	2.72e-06	3.13e-05	CcSEcCtD
Capecitabine—Urticaria—Dexamethasone—hematologic cancer	2.72e-06	3.13e-05	CcSEcCtD
Capecitabine—Urticaria—Betamethasone—hematologic cancer	2.72e-06	3.13e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—MTAP—hematologic cancer	2.72e-06	8.14e-05	CbGpPWpGaD
Capecitabine—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.72e-06	3.12e-05	CcSEcCtD
Capecitabine—Dizziness—Prednisolone—hematologic cancer	2.71e-06	3.12e-05	CcSEcCtD
Capecitabine—Arrhythmia—Doxorubicin—hematologic cancer	2.71e-06	3.12e-05	CcSEcCtD
Capecitabine—Asthenia—Triamcinolone—hematologic cancer	2.71e-06	3.11e-05	CcSEcCtD
Capecitabine—Body temperature increased—Dexamethasone—hematologic cancer	2.71e-06	3.11e-05	CcSEcCtD
Capecitabine—Abdominal pain—Dexamethasone—hematologic cancer	2.71e-06	3.11e-05	CcSEcCtD
Capecitabine—Abdominal pain—Betamethasone—hematologic cancer	2.71e-06	3.11e-05	CcSEcCtD
Capecitabine—Body temperature increased—Betamethasone—hematologic cancer	2.71e-06	3.11e-05	CcSEcCtD
Capecitabine—Nausea—Cisplatin—hematologic cancer	2.7e-06	3.1e-05	CcSEcCtD
Capecitabine—Insomnia—Prednisone—hematologic cancer	2.7e-06	3.1e-05	CcSEcCtD
Capecitabine—Vision blurred—Epirubicin—hematologic cancer	2.69e-06	3.1e-05	CcSEcCtD
Capecitabine—Alopecia—Doxorubicin—hematologic cancer	2.68e-06	3.09e-05	CcSEcCtD
Capecitabine—Paraesthesia—Prednisone—hematologic cancer	2.68e-06	3.08e-05	CcSEcCtD
Capecitabine—Pruritus—Triamcinolone—hematologic cancer	2.67e-06	3.07e-05	CcSEcCtD
Capecitabine—Cough—Methotrexate—hematologic cancer	2.66e-06	3.06e-05	CcSEcCtD
Capecitabine—Mental disorder—Doxorubicin—hematologic cancer	2.66e-06	3.06e-05	CcSEcCtD
Capecitabine—Ill-defined disorder—Epirubicin—hematologic cancer	2.65e-06	3.05e-05	CcSEcCtD
Capecitabine—Vomiting—Etoposide—hematologic cancer	2.64e-06	3.04e-05	CcSEcCtD
Capecitabine—Erythema—Doxorubicin—hematologic cancer	2.64e-06	3.04e-05	CcSEcCtD
Capecitabine—Malnutrition—Doxorubicin—hematologic cancer	2.64e-06	3.04e-05	CcSEcCtD
Capecitabine—Anaemia—Epirubicin—hematologic cancer	2.64e-06	3.04e-05	CcSEcCtD
Capecitabine—Dyspepsia—Prednisone—hematologic cancer	2.62e-06	3.02e-05	CcSEcCtD
Capecitabine—Rash—Etoposide—hematologic cancer	2.62e-06	3.02e-05	CcSEcCtD
Capecitabine—Dermatitis—Etoposide—hematologic cancer	2.62e-06	3.01e-05	CcSEcCtD
Capecitabine—Headache—Etoposide—hematologic cancer	2.61e-06	3e-05	CcSEcCtD
Capecitabine—Flatulence—Doxorubicin—hematologic cancer	2.6e-06	3e-05	CcSEcCtD
Capecitabine—Arthralgia—Methotrexate—hematologic cancer	2.6e-06	2.99e-05	CcSEcCtD
Capecitabine—Myalgia—Methotrexate—hematologic cancer	2.6e-06	2.99e-05	CcSEcCtD
Capecitabine—Chest pain—Methotrexate—hematologic cancer	2.6e-06	2.99e-05	CcSEcCtD
Capecitabine—Decreased appetite—Prednisone—hematologic cancer	2.59e-06	2.98e-05	CcSEcCtD
Capecitabine—Dysgeusia—Doxorubicin—hematologic cancer	2.59e-06	2.98e-05	CcSEcCtD
Capecitabine—Rash—Prednisolone—hematologic cancer	2.59e-06	2.98e-05	CcSEcCtD
Capecitabine—Dermatitis—Prednisolone—hematologic cancer	2.58e-06	2.97e-05	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.58e-06	2.97e-05	CcSEcCtD
Capecitabine—Malaise—Epirubicin—hematologic cancer	2.58e-06	2.96e-05	CcSEcCtD
Capecitabine—Fatigue—Prednisone—hematologic cancer	2.57e-06	2.96e-05	CcSEcCtD
Capecitabine—Headache—Prednisolone—hematologic cancer	2.57e-06	2.96e-05	CcSEcCtD
Capecitabine—Discomfort—Methotrexate—hematologic cancer	2.57e-06	2.95e-05	CcSEcCtD
Capecitabine—Vertigo—Epirubicin—hematologic cancer	2.57e-06	2.95e-05	CcSEcCtD
Capecitabine—Syncope—Epirubicin—hematologic cancer	2.56e-06	2.95e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—TP53—hematologic cancer	2.56e-06	7.67e-05	CbGpPWpGaD
Capecitabine—Leukopenia—Epirubicin—hematologic cancer	2.56e-06	2.94e-05	CcSEcCtD
Capecitabine—Back pain—Doxorubicin—hematologic cancer	2.56e-06	2.94e-05	CcSEcCtD
Capecitabine—DPYD—Metabolism—AKT1—hematologic cancer	2.55e-06	7.64e-05	CbGpPWpGaD
Capecitabine—Constipation—Prednisone—hematologic cancer	2.55e-06	2.93e-05	CcSEcCtD
Capecitabine—Muscle spasms—Doxorubicin—hematologic cancer	2.54e-06	2.92e-05	CcSEcCtD
Capecitabine—Palpitations—Epirubicin—hematologic cancer	2.52e-06	2.9e-05	CcSEcCtD
Capecitabine—Confusional state—Methotrexate—hematologic cancer	2.51e-06	2.89e-05	CcSEcCtD
Capecitabine—Loss of consciousness—Epirubicin—hematologic cancer	2.51e-06	2.89e-05	CcSEcCtD
Capecitabine—Dizziness—Triamcinolone—hematologic cancer	2.49e-06	2.87e-05	CcSEcCtD
Capecitabine—Cough—Epirubicin—hematologic cancer	2.49e-06	2.87e-05	CcSEcCtD
Capecitabine—Vision blurred—Doxorubicin—hematologic cancer	2.49e-06	2.87e-05	CcSEcCtD
Capecitabine—Infection—Methotrexate—hematologic cancer	2.47e-06	2.85e-05	CcSEcCtD
Capecitabine—Nausea—Etoposide—hematologic cancer	2.47e-06	2.84e-05	CcSEcCtD
Capecitabine—Hypertension—Epirubicin—hematologic cancer	2.47e-06	2.84e-05	CcSEcCtD
Capecitabine—Feeling abnormal—Prednisone—hematologic cancer	2.46e-06	2.83e-05	CcSEcCtD
Capecitabine—Asthenia—Betamethasone—hematologic cancer	2.46e-06	2.82e-05	CcSEcCtD
Capecitabine—Asthenia—Dexamethasone—hematologic cancer	2.46e-06	2.82e-05	CcSEcCtD
Capecitabine—Ill-defined disorder—Doxorubicin—hematologic cancer	2.45e-06	2.82e-05	CcSEcCtD
Capecitabine—Nervous system disorder—Methotrexate—hematologic cancer	2.44e-06	2.81e-05	CcSEcCtD
Capecitabine—Anaemia—Doxorubicin—hematologic cancer	2.44e-06	2.81e-05	CcSEcCtD
Capecitabine—Thrombocytopenia—Methotrexate—hematologic cancer	2.44e-06	2.81e-05	CcSEcCtD
Capecitabine—Gastrointestinal pain—Prednisone—hematologic cancer	2.44e-06	2.8e-05	CcSEcCtD
Capecitabine—Nausea—Prednisolone—hematologic cancer	2.44e-06	2.8e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—PIK3CG—hematologic cancer	2.43e-06	7.29e-05	CbGpPWpGaD
Capecitabine—Myalgia—Epirubicin—hematologic cancer	2.43e-06	2.8e-05	CcSEcCtD
Capecitabine—Chest pain—Epirubicin—hematologic cancer	2.43e-06	2.8e-05	CcSEcCtD
Capecitabine—Arthralgia—Epirubicin—hematologic cancer	2.43e-06	2.8e-05	CcSEcCtD
Capecitabine—Anxiety—Epirubicin—hematologic cancer	2.42e-06	2.79e-05	CcSEcCtD
Capecitabine—Pruritus—Betamethasone—hematologic cancer	2.42e-06	2.79e-05	CcSEcCtD
Capecitabine—Pruritus—Dexamethasone—hematologic cancer	2.42e-06	2.79e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—FHL2—hematologic cancer	2.42e-06	7.25e-05	CbGpPWpGaD
Capecitabine—Skin disorder—Methotrexate—hematologic cancer	2.42e-06	2.78e-05	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.41e-06	2.78e-05	CcSEcCtD
Capecitabine—Hyperhidrosis—Methotrexate—hematologic cancer	2.41e-06	2.77e-05	CcSEcCtD
Capecitabine—Discomfort—Epirubicin—hematologic cancer	2.4e-06	2.76e-05	CcSEcCtD
Capecitabine—Vomiting—Triamcinolone—hematologic cancer	2.4e-06	2.76e-05	CcSEcCtD
Capecitabine—Malaise—Doxorubicin—hematologic cancer	2.38e-06	2.74e-05	CcSEcCtD
Capecitabine—Rash—Triamcinolone—hematologic cancer	2.38e-06	2.74e-05	CcSEcCtD
Capecitabine—Dry mouth—Epirubicin—hematologic cancer	2.38e-06	2.74e-05	CcSEcCtD
Capecitabine—Dermatitis—Triamcinolone—hematologic cancer	2.38e-06	2.73e-05	CcSEcCtD
Capecitabine—Vertigo—Doxorubicin—hematologic cancer	2.37e-06	2.73e-05	CcSEcCtD
Capecitabine—Anorexia—Methotrexate—hematologic cancer	2.37e-06	2.73e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—AGRN—hematologic cancer	2.37e-06	7.11e-05	CbGpPWpGaD
Capecitabine—Syncope—Doxorubicin—hematologic cancer	2.37e-06	2.73e-05	CcSEcCtD
Capecitabine—Urticaria—Prednisone—hematologic cancer	2.37e-06	2.72e-05	CcSEcCtD
Capecitabine—Leukopenia—Doxorubicin—hematologic cancer	2.37e-06	2.72e-05	CcSEcCtD
Capecitabine—Headache—Triamcinolone—hematologic cancer	2.36e-06	2.72e-05	CcSEcCtD
Capecitabine—Abdominal pain—Prednisone—hematologic cancer	2.36e-06	2.71e-05	CcSEcCtD
Capecitabine—Body temperature increased—Prednisone—hematologic cancer	2.36e-06	2.71e-05	CcSEcCtD
Capecitabine—Confusional state—Epirubicin—hematologic cancer	2.35e-06	2.7e-05	CcSEcCtD
Capecitabine—Diarrhoea—Betamethasone—hematologic cancer	2.34e-06	2.69e-05	CcSEcCtD
Capecitabine—Diarrhoea—Dexamethasone—hematologic cancer	2.34e-06	2.69e-05	CcSEcCtD
Capecitabine—Palpitations—Doxorubicin—hematologic cancer	2.34e-06	2.69e-05	CcSEcCtD
Capecitabine—Oedema—Epirubicin—hematologic cancer	2.33e-06	2.68e-05	CcSEcCtD
Capecitabine—Hypotension—Methotrexate—hematologic cancer	2.33e-06	2.68e-05	CcSEcCtD
Capecitabine—Loss of consciousness—Doxorubicin—hematologic cancer	2.32e-06	2.67e-05	CcSEcCtD
Capecitabine—Infection—Epirubicin—hematologic cancer	2.32e-06	2.66e-05	CcSEcCtD
Capecitabine—Cough—Doxorubicin—hematologic cancer	2.31e-06	2.65e-05	CcSEcCtD
Capecitabine—Shock—Epirubicin—hematologic cancer	2.29e-06	2.64e-05	CcSEcCtD
Capecitabine—Nervous system disorder—Epirubicin—hematologic cancer	2.29e-06	2.63e-05	CcSEcCtD
Capecitabine—Thrombocytopenia—Epirubicin—hematologic cancer	2.28e-06	2.63e-05	CcSEcCtD
Capecitabine—Hypertension—Doxorubicin—hematologic cancer	2.28e-06	2.62e-05	CcSEcCtD
Capecitabine—Tachycardia—Epirubicin—hematologic cancer	2.28e-06	2.62e-05	CcSEcCtD
Capecitabine—CDA—Metabolism—AKT1—hematologic cancer	2.27e-06	6.81e-05	CbGpPWpGaD
Capecitabine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.27e-06	2.61e-05	CcSEcCtD
Capecitabine—Skin disorder—Epirubicin—hematologic cancer	2.26e-06	2.6e-05	CcSEcCtD
Capecitabine—Dizziness—Betamethasone—hematologic cancer	2.26e-06	2.6e-05	CcSEcCtD
Capecitabine—Dizziness—Dexamethasone—hematologic cancer	2.26e-06	2.6e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—CREBBP—hematologic cancer	2.26e-06	6.76e-05	CbGpPWpGaD
Capecitabine—Hyperhidrosis—Epirubicin—hematologic cancer	2.25e-06	2.59e-05	CcSEcCtD
Capecitabine—Insomnia—Methotrexate—hematologic cancer	2.25e-06	2.59e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—IDH2—hematologic cancer	2.25e-06	6.74e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HMMR—hematologic cancer	2.25e-06	6.74e-05	CbGpPWpGaD
Capecitabine—Chest pain—Doxorubicin—hematologic cancer	2.25e-06	2.59e-05	CcSEcCtD
Capecitabine—Myalgia—Doxorubicin—hematologic cancer	2.25e-06	2.59e-05	CcSEcCtD
Capecitabine—Arthralgia—Doxorubicin—hematologic cancer	2.25e-06	2.59e-05	CcSEcCtD
Capecitabine—Anxiety—Doxorubicin—hematologic cancer	2.24e-06	2.58e-05	CcSEcCtD
Capecitabine—Nausea—Triamcinolone—hematologic cancer	2.24e-06	2.58e-05	CcSEcCtD
Capecitabine—Paraesthesia—Methotrexate—hematologic cancer	2.24e-06	2.57e-05	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.23e-06	2.57e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—PIK3CA—hematologic cancer	2.22e-06	6.66e-05	CbGpPWpGaD
Capecitabine—Discomfort—Doxorubicin—hematologic cancer	2.22e-06	2.56e-05	CcSEcCtD
Capecitabine—Anorexia—Epirubicin—hematologic cancer	2.22e-06	2.56e-05	CcSEcCtD
Capecitabine—Dyspnoea—Methotrexate—hematologic cancer	2.22e-06	2.55e-05	CcSEcCtD
Capecitabine—Dry mouth—Doxorubicin—hematologic cancer	2.2e-06	2.53e-05	CcSEcCtD
Capecitabine—Hypersensitivity—Prednisone—hematologic cancer	2.2e-06	2.53e-05	CcSEcCtD
Capecitabine—Dyspepsia—Methotrexate—hematologic cancer	2.19e-06	2.52e-05	CcSEcCtD
Capecitabine—Hypotension—Epirubicin—hematologic cancer	2.18e-06	2.51e-05	CcSEcCtD
Capecitabine—Vomiting—Betamethasone—hematologic cancer	2.18e-06	2.5e-05	CcSEcCtD
Capecitabine—Vomiting—Dexamethasone—hematologic cancer	2.18e-06	2.5e-05	CcSEcCtD
Capecitabine—Confusional state—Doxorubicin—hematologic cancer	2.17e-06	2.5e-05	CcSEcCtD
Capecitabine—Decreased appetite—Methotrexate—hematologic cancer	2.17e-06	2.49e-05	CcSEcCtD
Capecitabine—Rash—Betamethasone—hematologic cancer	2.16e-06	2.48e-05	CcSEcCtD
Capecitabine—Rash—Dexamethasone—hematologic cancer	2.16e-06	2.48e-05	CcSEcCtD
Capecitabine—Oedema—Doxorubicin—hematologic cancer	2.16e-06	2.48e-05	CcSEcCtD
Capecitabine—Dermatitis—Betamethasone—hematologic cancer	2.16e-06	2.48e-05	CcSEcCtD
Capecitabine—Dermatitis—Dexamethasone—hematologic cancer	2.16e-06	2.48e-05	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.15e-06	2.47e-05	CcSEcCtD
Capecitabine—Fatigue—Methotrexate—hematologic cancer	2.15e-06	2.47e-05	CcSEcCtD
Capecitabine—Headache—Betamethasone—hematologic cancer	2.14e-06	2.47e-05	CcSEcCtD
Capecitabine—Headache—Dexamethasone—hematologic cancer	2.14e-06	2.47e-05	CcSEcCtD
Capecitabine—Infection—Doxorubicin—hematologic cancer	2.14e-06	2.47e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—PIK3CD—hematologic cancer	2.14e-06	6.41e-05	CbGpPWpGaD
Capecitabine—Asthenia—Prednisone—hematologic cancer	2.14e-06	2.46e-05	CcSEcCtD
Capecitabine—Pain—Methotrexate—hematologic cancer	2.13e-06	2.45e-05	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.12e-06	2.44e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	2.12e-06	6.36e-05	CbGpPWpGaD
Capecitabine—Shock—Doxorubicin—hematologic cancer	2.12e-06	2.44e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—ARNTL—hematologic cancer	2.12e-06	6.34e-05	CbGpPWpGaD
Capecitabine—Nervous system disorder—Doxorubicin—hematologic cancer	2.12e-06	2.43e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—ALB—hematologic cancer	2.11e-06	6.33e-05	CbGpPWpGaD
Capecitabine—Thrombocytopenia—Doxorubicin—hematologic cancer	2.11e-06	2.43e-05	CcSEcCtD
Capecitabine—Pruritus—Prednisone—hematologic cancer	2.11e-06	2.43e-05	CcSEcCtD
Capecitabine—Insomnia—Epirubicin—hematologic cancer	2.11e-06	2.43e-05	CcSEcCtD
Capecitabine—Tachycardia—Doxorubicin—hematologic cancer	2.11e-06	2.42e-05	CcSEcCtD
Capecitabine—Skin disorder—Doxorubicin—hematologic cancer	2.09e-06	2.41e-05	CcSEcCtD
Capecitabine—Paraesthesia—Epirubicin—hematologic cancer	2.09e-06	2.41e-05	CcSEcCtD
Capecitabine—Hyperhidrosis—Doxorubicin—hematologic cancer	2.09e-06	2.4e-05	CcSEcCtD
Capecitabine—Dyspnoea—Epirubicin—hematologic cancer	2.08e-06	2.39e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—CA9—hematologic cancer	2.06e-06	6.17e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ACP5—hematologic cancer	2.06e-06	6.17e-05	CbGpPWpGaD
Capecitabine—Anorexia—Doxorubicin—hematologic cancer	2.06e-06	2.37e-05	CcSEcCtD
Capecitabine—Feeling abnormal—Methotrexate—hematologic cancer	2.05e-06	2.36e-05	CcSEcCtD
Capecitabine—Dyspepsia—Epirubicin—hematologic cancer	2.05e-06	2.36e-05	CcSEcCtD
Capecitabine—Diarrhoea—Prednisone—hematologic cancer	2.04e-06	2.35e-05	CcSEcCtD
Capecitabine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.04e-06	2.34e-05	CcSEcCtD
Capecitabine—Nausea—Dexamethasone—hematologic cancer	2.03e-06	2.34e-05	CcSEcCtD
Capecitabine—Nausea—Betamethasone—hematologic cancer	2.03e-06	2.34e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—NCOR2—hematologic cancer	2.03e-06	6.09e-05	CbGpPWpGaD
Capecitabine—Decreased appetite—Epirubicin—hematologic cancer	2.03e-06	2.33e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—PIK3R1—hematologic cancer	2.02e-06	6.05e-05	CbGpPWpGaD
Capecitabine—Hypotension—Doxorubicin—hematologic cancer	2.02e-06	2.32e-05	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.01e-06	2.32e-05	CcSEcCtD
Capecitabine—Fatigue—Epirubicin—hematologic cancer	2.01e-06	2.31e-05	CcSEcCtD
Capecitabine—Pain—Epirubicin—hematologic cancer	1.99e-06	2.29e-05	CcSEcCtD
Capecitabine—Constipation—Epirubicin—hematologic cancer	1.99e-06	2.29e-05	CcSEcCtD
Capecitabine—Urticaria—Methotrexate—hematologic cancer	1.98e-06	2.28e-05	CcSEcCtD
Capecitabine—Dizziness—Prednisone—hematologic cancer	1.97e-06	2.27e-05	CcSEcCtD
Capecitabine—Abdominal pain—Methotrexate—hematologic cancer	1.97e-06	2.27e-05	CcSEcCtD
Capecitabine—Body temperature increased—Methotrexate—hematologic cancer	1.97e-06	2.27e-05	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.97e-06	2.26e-05	CcSEcCtD
Capecitabine—Insomnia—Doxorubicin—hematologic cancer	1.95e-06	2.24e-05	CcSEcCtD
Capecitabine—Paraesthesia—Doxorubicin—hematologic cancer	1.94e-06	2.23e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—IDH1—hematologic cancer	1.94e-06	5.8e-05	CbGpPWpGaD
Capecitabine—Dyspnoea—Doxorubicin—hematologic cancer	1.92e-06	2.21e-05	CcSEcCtD
Capecitabine—Feeling abnormal—Epirubicin—hematologic cancer	1.92e-06	2.21e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—ABCC3—hematologic cancer	1.91e-06	5.73e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTO1—hematologic cancer	1.91e-06	5.73e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—TXN—hematologic cancer	1.91e-06	5.73e-05	CbGpPWpGaD
Capecitabine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.91e-06	2.19e-05	CcSEcCtD
Capecitabine—Dyspepsia—Doxorubicin—hematologic cancer	1.9e-06	2.18e-05	CcSEcCtD
Capecitabine—Vomiting—Prednisone—hematologic cancer	1.9e-06	2.18e-05	CcSEcCtD
Capecitabine—Rash—Prednisone—hematologic cancer	1.88e-06	2.16e-05	CcSEcCtD
Capecitabine—Dermatitis—Prednisone—hematologic cancer	1.88e-06	2.16e-05	CcSEcCtD
Capecitabine—Decreased appetite—Doxorubicin—hematologic cancer	1.87e-06	2.16e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—SPHK1—hematologic cancer	1.87e-06	5.61e-05	CbGpPWpGaD
Capecitabine—Headache—Prednisone—hematologic cancer	1.87e-06	2.15e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—PIK3CB—hematologic cancer	1.87e-06	5.59e-05	CbGpPWpGaD
Capecitabine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.86e-06	2.14e-05	CcSEcCtD
Capecitabine—Fatigue—Doxorubicin—hematologic cancer	1.86e-06	2.14e-05	CcSEcCtD
Capecitabine—Urticaria—Epirubicin—hematologic cancer	1.85e-06	2.13e-05	CcSEcCtD
Capecitabine—Constipation—Doxorubicin—hematologic cancer	1.84e-06	2.12e-05	CcSEcCtD
Capecitabine—Pain—Doxorubicin—hematologic cancer	1.84e-06	2.12e-05	CcSEcCtD
Capecitabine—Abdominal pain—Epirubicin—hematologic cancer	1.84e-06	2.12e-05	CcSEcCtD
Capecitabine—Body temperature increased—Epirubicin—hematologic cancer	1.84e-06	2.12e-05	CcSEcCtD
Capecitabine—Hypersensitivity—Methotrexate—hematologic cancer	1.84e-06	2.11e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—AKT1—hematologic cancer	1.82e-06	5.44e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—UGT1A1—hematologic cancer	1.8e-06	5.39e-05	CbGpPWpGaD
Capecitabine—Asthenia—Methotrexate—hematologic cancer	1.79e-06	2.06e-05	CcSEcCtD
Capecitabine—Feeling abnormal—Doxorubicin—hematologic cancer	1.78e-06	2.04e-05	CcSEcCtD
Capecitabine—Nausea—Prednisone—hematologic cancer	1.77e-06	2.04e-05	CcSEcCtD
Capecitabine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.76e-06	2.03e-05	CcSEcCtD
Capecitabine—Pruritus—Methotrexate—hematologic cancer	1.76e-06	2.03e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—SLC22A1—hematologic cancer	1.75e-06	5.24e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CRABP1—hematologic cancer	1.75e-06	5.24e-05	CbGpPWpGaD
Capecitabine—Hypersensitivity—Epirubicin—hematologic cancer	1.72e-06	1.98e-05	CcSEcCtD
Capecitabine—Urticaria—Doxorubicin—hematologic cancer	1.71e-06	1.97e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—ALOX5—hematologic cancer	1.71e-06	5.11e-05	CbGpPWpGaD
Capecitabine—Abdominal pain—Doxorubicin—hematologic cancer	1.71e-06	1.96e-05	CcSEcCtD
Capecitabine—Body temperature increased—Doxorubicin—hematologic cancer	1.71e-06	1.96e-05	CcSEcCtD
Capecitabine—Diarrhoea—Methotrexate—hematologic cancer	1.7e-06	1.96e-05	CcSEcCtD
Capecitabine—Asthenia—Epirubicin—hematologic cancer	1.67e-06	1.92e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—NUP98—hematologic cancer	1.65e-06	4.95e-05	CbGpPWpGaD
Capecitabine—Pruritus—Epirubicin—hematologic cancer	1.65e-06	1.9e-05	CcSEcCtD
Capecitabine—Dizziness—Methotrexate—hematologic cancer	1.65e-06	1.89e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—PTEN—hematologic cancer	1.61e-06	4.83e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ADCY7—hematologic cancer	1.6e-06	4.8e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NCOA3—hematologic cancer	1.6e-06	4.8e-05	CbGpPWpGaD
Capecitabine—Diarrhoea—Epirubicin—hematologic cancer	1.59e-06	1.83e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—NUP214—hematologic cancer	1.59e-06	4.77e-05	CbGpPWpGaD
Capecitabine—Hypersensitivity—Doxorubicin—hematologic cancer	1.59e-06	1.83e-05	CcSEcCtD
Capecitabine—Vomiting—Methotrexate—hematologic cancer	1.58e-06	1.82e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.58e-06	4.72e-05	CbGpPWpGaD
Capecitabine—Rash—Methotrexate—hematologic cancer	1.57e-06	1.81e-05	CcSEcCtD
Capecitabine—Dermatitis—Methotrexate—hematologic cancer	1.57e-06	1.81e-05	CcSEcCtD
Capecitabine—Headache—Methotrexate—hematologic cancer	1.56e-06	1.8e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—MTR—hematologic cancer	1.56e-06	4.67e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ABCG2—hematologic cancer	1.56e-06	4.67e-05	CbGpPWpGaD
Capecitabine—Asthenia—Doxorubicin—hematologic cancer	1.55e-06	1.78e-05	CcSEcCtD
Capecitabine—Dizziness—Epirubicin—hematologic cancer	1.54e-06	1.77e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—EP300—hematologic cancer	1.54e-06	4.61e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ENO2—hematologic cancer	1.53e-06	4.58e-05	CbGpPWpGaD
Capecitabine—Pruritus—Doxorubicin—hematologic cancer	1.53e-06	1.76e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—GSTT1—hematologic cancer	1.48e-06	4.44e-05	CbGpPWpGaD
Capecitabine—Vomiting—Epirubicin—hematologic cancer	1.48e-06	1.71e-05	CcSEcCtD
Capecitabine—Nausea—Methotrexate—hematologic cancer	1.48e-06	1.7e-05	CcSEcCtD
Capecitabine—Diarrhoea—Doxorubicin—hematologic cancer	1.48e-06	1.7e-05	CcSEcCtD
Capecitabine—Rash—Epirubicin—hematologic cancer	1.47e-06	1.69e-05	CcSEcCtD
Capecitabine—Dermatitis—Epirubicin—hematologic cancer	1.47e-06	1.69e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.46e-06	4.38e-05	CbGpPWpGaD
Capecitabine—Headache—Epirubicin—hematologic cancer	1.46e-06	1.68e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—SDC1—hematologic cancer	1.45e-06	4.34e-05	CbGpPWpGaD
Capecitabine—Dizziness—Doxorubicin—hematologic cancer	1.43e-06	1.64e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.39e-06	4.15e-05	CbGpPWpGaD
Capecitabine—Nausea—Epirubicin—hematologic cancer	1.38e-06	1.59e-05	CcSEcCtD
Capecitabine—Vomiting—Doxorubicin—hematologic cancer	1.37e-06	1.58e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.37e-06	4.1e-05	CbGpPWpGaD
Capecitabine—Rash—Doxorubicin—hematologic cancer	1.36e-06	1.56e-05	CcSEcCtD
Capecitabine—Dermatitis—Doxorubicin—hematologic cancer	1.36e-06	1.56e-05	CcSEcCtD
Capecitabine—Headache—Doxorubicin—hematologic cancer	1.35e-06	1.55e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.31e-06	3.92e-05	CbGpPWpGaD
Capecitabine—Nausea—Doxorubicin—hematologic cancer	1.28e-06	1.47e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—NQO1—hematologic cancer	1.23e-06	3.69e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CD44—hematologic cancer	1.23e-06	3.69e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.21e-06	3.62e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYCS—hematologic cancer	1.17e-06	3.5e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	1.16e-06	3.47e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CA—hematologic cancer	1.14e-06	3.41e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.04e-06	3.13e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTP1—hematologic cancer	1.03e-06	3.08e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	9.95e-07	2.98e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ABCB1—hematologic cancer	9.74e-07	2.92e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NCOR1—hematologic cancer	9.45e-07	2.83e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTM1—hematologic cancer	9.45e-07	2.83e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AKT1—hematologic cancer	9.29e-07	2.78e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—MTHFR—hematologic cancer	8.35e-07	2.5e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7.36e-07	2.21e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	7.02e-07	2.1e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CREBBP—hematologic cancer	6.51e-07	1.95e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	6.17e-07	1.85e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALB—hematologic cancer	6.09e-07	1.82e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	5.83e-07	1.75e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	5.38e-07	1.61e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTEN—hematologic cancer	4.65e-07	1.39e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—EP300—hematologic cancer	4.43e-07	1.33e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	3.28e-07	9.82e-06	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AKT1—hematologic cancer	2.68e-07	8.02e-06	CbGpPWpGaD
